Literature DB >> 24344134

PIASxα ligase enhances SUMO1 modification of PTEN protein as a SUMO E3 ligase.

Weibin Wang1, Yifan Chen, Shuya Wang, Ningguang Hu, Zhengyi Cao, Wengong Wang, Tanjun Tong, Xiaowei Zhang.   

Abstract

The tumor suppressor PTEN plays a critical role in the regulation of multiple cellular processes that include survival, cell cycle, proliferation, and apoptosis. PTEN is frequently mutated or deleted in various human cancer cells to promote tumorigenesis. PTEN is regulated by SUMOylation, but the SUMO E3 ligase involved in the SUMOylation of PTEN remains unclear. Here, we demonstrated that PIASxα is a SUMO E3 ligase for PTEN. PIASxα physically interacted with PTEN both in vitro and in vivo. Their interaction depended on the integrity of phosphatase and C2 domains of PTEN and the region of PIASxα comprising residues 134-347. PIASxα enhanced PTEN protein stability by reducing PTEN ubiquitination, whereas the mutation of PTEN SUMO1 conjugation sites neutralized the effect of PIASxα on PTEN protein half-life. Functionally, PIASxα, as a potential tumor suppressor, negatively regulated the PI3K-Akt pathway through stabilizing PTEN protein. Overexpression of PIASxα led to G0/G1 cell cycle arrest, thus triggering cell proliferation inhibition and tumor suppression, whereas PIASxα knockdown or deficiency in catalytic activity abolished the inhibition. Together our studies suggest that PIASxα is a novel SUMO E3 ligase for PTEN, and it positively regulates PTEN protein level in tumor suppression.

Entities:  

Keywords:  PI 3-Kinase (PI3K); PIASxα; PTEN; SUMO E3 Ligase; Sumoylation; Tumor; Tumor Inhibition; Ubiquitination

Mesh:

Substances:

Year:  2013        PMID: 24344134      PMCID: PMC3916526          DOI: 10.1074/jbc.M113.508515

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  The polycomb protein Pc2 is a SUMO E3.

Authors:  Michael H Kagey; Tiffany A Melhuish; David Wotton
Journal:  Cell       Date:  2003-04-04       Impact factor: 41.582

Review 2.  PIAS/SUMO: new partners in transcriptional regulation.

Authors:  D Schmidt; S Müller
Journal:  Cell Mol Life Sci       Date:  2003-12       Impact factor: 9.261

3.  Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN.

Authors:  M Tamura; J Gu; K Matsumoto; S Aota; R Parsons; K M Yamada
Journal:  Science       Date:  1998-06-05       Impact factor: 47.728

4.  Ubch9 conjugates SUMO but not ubiquitin.

Authors:  J M Desterro; J Thomson; R T Hay
Journal:  FEBS Lett       Date:  1997-11-17       Impact factor: 4.124

5.  Expression profile of the putative catalytic subunit of the telomerase gene.

Authors:  S Ramakrishnan; U Eppenberger; H Mueller; Y Shinkai; R Narayanan
Journal:  Cancer Res       Date:  1998-02-15       Impact factor: 12.701

6.  SUMO1 modification of PTEN regulates tumorigenesis by controlling its association with the plasma membrane.

Authors:  Jian Huang; Jie Yan; Jian Zhang; Shiguo Zhu; Yanli Wang; Ting Shi; Changhong Zhu; Cheng Chen; Xin Liu; Jinke Cheng; Tomas Mustelin; Gen-Sheng Feng; Guoqiang Chen; Jianxiu Yu
Journal:  Nat Commun       Date:  2012-06-19       Impact factor: 14.919

7.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.

Authors:  P A Steck; M A Pershouse; S A Jasser; W K Yung; H Lin; A H Ligon; L A Langford; M L Baumgard; T Hattier; T Davis; C Frye; R Hu; B Swedlund; D H Teng; S V Tavtigian
Journal:  Nat Genet       Date:  1997-04       Impact factor: 38.330

8.  MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.

Authors:  D H Teng; R Hu; H Lin; T Davis; D Iliev; C Frye; B Swedlund; K L Hansen; V L Vinson; K L Gumpper; L Ellis; A El-Naggar; M Frazier; S Jasser; L A Langford; J Lee; G B Mills; M A Pershouse; R E Pollack; C Tornos; P Troncoso; W K Yung; G Fujii; A Berson; P A Steck
Journal:  Cancer Res       Date:  1997-12-01       Impact factor: 12.701

9.  PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.

Authors:  J Li; C Yen; D Liaw; K Podsypanina; S Bose; S I Wang; J Puc; C Miliaresis; L Rodgers; R McCombie; S H Bigner; B C Giovanella; M Ittmann; B Tycko; H Hibshoosh; M H Wigler; R Parsons
Journal:  Science       Date:  1997-03-28       Impact factor: 47.728

10.  Structure determination of the small ubiquitin-related modifier SUMO-1.

Authors:  P Bayer; A Arndt; S Metzger; R Mahajan; F Melchior; R Jaenicke; J Becker
Journal:  J Mol Biol       Date:  1998-07-10       Impact factor: 5.469

View more
  19 in total

1.  The significance of SUMOylation of angiogenic factors in cancer progression.

Authors:  Mei Wang; Xiaodong Jiang
Journal:  Cancer Biol Ther       Date:  2018-09-27       Impact factor: 4.742

2.  A positive feedback loop between Pim-1 kinase and HBP1 transcription factor contributes to hydrogen peroxide-induced premature senescence and apoptosis.

Authors:  Shuya Wang; Zhengyi Cao; Junhui Xue; Hui Li; Wei Jiang; Yuning Cheng; Gang Li; Xiaowei Zhang
Journal:  J Biol Chem       Date:  2017-03-27       Impact factor: 5.157

3.  Sumoylation of influenza A virus nucleoprotein is essential for intracellular trafficking and virus growth.

Authors:  Qinglin Han; Chong Chang; Li Li; Christoph Klenk; Jinke Cheng; Yixin Chen; Ningshao Xia; Yuelong Shu; Ze Chen; Gülsah Gabriel; Bing Sun; Ke Xu
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

Review 4.  Posttranslational Regulation and Conformational Plasticity of PTEN.

Authors:  Larissa Kotelevets; Barbara Trifault; Eric Chastre; Mark G H Scott
Journal:  Cold Spring Harb Perspect Med       Date:  2020-07-01       Impact factor: 5.159

Review 5.  Roles of ubiquitination and SUMOylation on prostate cancer: mechanisms and clinical implications.

Authors:  Zhenbang Chen; Wenfu Lu
Journal:  Int J Mol Sci       Date:  2015-02-27       Impact factor: 5.923

6.  Lung neuroendocrine tumors: correlation of ubiquitinylation and sumoylation with nucleo-cytosolic partitioning of PTEN.

Authors:  Stéphane Collaud; Verena Tischler; Andrej Atanassoff; Thomas Wiedl; Paul Komminoth; Christian Oehlschlegel; Walter Weder; Alex Soltermann
Journal:  BMC Cancer       Date:  2015-02-20       Impact factor: 4.430

7.  SENP1 regulates PTEN stability to dictate prostate cancer development.

Authors:  Tasneem Bawa-Khalfe; Feng-Ming Yang; Joan Ritho; Hui-Kuan Lin; Jinke Cheng; Edward T H Yeh
Journal:  Oncotarget       Date:  2017-03-14

8.  SUMOylation of TARBP2 regulates miRNA/siRNA efficiency.

Authors:  Cheng Chen; Changhong Zhu; Jian Huang; Xian Zhao; Rong Deng; Hailong Zhang; Jinzhuo Dou; Qin Chen; Ming Xu; Haihua Yuan; Yanli Wang; Jianxiu Yu
Journal:  Nat Commun       Date:  2015-11-19       Impact factor: 14.919

9.  HBP1-mediated Regulation of p21 Protein through the Mdm2/p53 and TCF4/EZH2 Pathways and Its Impact on Cell Senescence and Tumorigenesis.

Authors:  Yifan Chen; Kewu Pan; Pingzhang Wang; Zhengyi Cao; Weibin Wang; Shuya Wang; Ningguang Hu; Junhui Xue; Hui Li; Wei Jiang; Gang Li; Xiaowei Zhang
Journal:  J Biol Chem       Date:  2016-04-21       Impact factor: 5.157

10.  RSUME is implicated in tumorigenesis and metastasis of pancreatic neuroendocrine tumors.

Authors:  Yonghe Wu; Lucas Tedesco; Kristin Lucia; Anna M Schlitter; Jose Monteserin Garcia; Irene Esposito; Christoph J Auernhammer; Marily Theodoropoulou; Eduardo Arzt; Ulrich Renner; Günter K Stalla
Journal:  Oncotarget       Date:  2016-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.